Transforming Transplant-Eligible Newly Diagnosed Multiple Myeloma: From Real-World Evidence to Clinical Practice

home / frontline-forum / transforming-transplant-eligible-newly-diagnosed-multiple-myeloma-from-real-world-evidence-to

Luciano Costa, MD, PhD and Timothy Schmidt, MD discuss key data updates and share pearls for community oncologists concerning transplant-eligible newly diagnosed multiple myeloma (NDMM).

An Introduction to NDMM: Treatment Options and Patient Risk Stratification

EP. 1: An Introduction to NDMM: Treatment Options and Patient Risk Stratification

Luciano Costa, MD, PhD;Timothy Schmidt, MD
June 22nd 2023

Luciano Costa, MD, PhD and Timothy Schmidt, MD introduce treatment regimen options and risk stratification for patients with transplant-eligible NDMM.

Clinical Insights from the Results of the MASTER Trial

EP. 2: Clinical Insights from the Results of the MASTER Trial

Luciano Costa, MD, PhD;Timothy Schmidt, MD
June 22nd 2023

Thoughtful discussion centered around recently presented updates to the MASTER trial.

Key Data and Outcomes from the GRIFFIN Trial

EP. 3: Key Data and Outcomes from the GRIFFIN Trial

Luciano Costa, MD, PhD;Timothy Schmidt, MD
July 20th 2023

A summary of updates from the GRIFFIN trial evaluating D-RVd in clinically relevant NDMM patient subgroups.

A Practical Approach to Treatment Selection for Patients with NDMM

EP. 4: A Practical Approach to Treatment Selection for Patients with NDMM

Luciano Costa, MD, PhD;Timothy Schmidt, MD
July 20th 2023

Subject-matter experts share their perspectives on treatment selection for patients with NDMM.

Optimizing Consolidation and Maintenance Therapy in the NDMM Treatment Landscape

EP. 5: Optimizing Consolidation and Maintenance Therapy in the NDMM Treatment Landscape

Luciano Costa, MD, PhD;Timothy Schmidt, MD
July 27th 2023

Experienced clinicians share their perspectives on maintenance therapy for patients with NDMM.

The Future of the NDMM: Comparing Emergent Regimens and Understanding Unmet Needs

EP. 6: The Future of the NDMM: Comparing Emergent Regimens and Understanding Unmet Needs

Luciano Costa, MD, PhD;Timothy Schmidt, MD
July 27th 2023

Dr. Costa and Dr. Schmidt consider promising emergent treatment options and current unmet needs in the NDMM treatment landscape.

Recap: Available Treatment Options in Transplant-Eligible Multiple Myeloma

EP. 7: Recap: Available Treatment Options in Transplant-Eligible Multiple Myeloma

ONCOLOGY Staff
July 30th 2023

Experts in the multiple myeloma space discuss recent developments and how to implement new practices in real-world settings.